Kwan-lung H. Ko
4/F, Pokfulam Road 102, Pok Fu Lam
Hong Kong, HCW, Hong Kong Special Administrative Region
Hong Kong, HCW, Hong Kong Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Surveillance of hepatocellular carcinoma (HCC) patients using Protein Induced by Vitamin K (PIVKA-II): A cost-utility analysis for Hong Kong.
Journal: PloS one
Published: September 19, 2025
Pilot model of hepatitis C virus micro-elimination in high-risk populations in Hong Kong: Barriers and facilitators.
Journal: The International journal on drug policy
Published: April 13, 2024
Editorial: optimising hepatitis B vaccine response in inflammatory bowel disease-time to get some skin in the game. Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: June 24, 2022
Clinical trial: intra dermal hepatitis B vaccination with topical imiquimod versus intra muscular hepatitis B vaccination in patients with inflammatory bowel disease.
Journal: Alimentary pharmacology & therapeutics
Published: February 24, 2022
Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy.
Journal: Journal of gastroenterology
Published: December 23, 2020
Hepatocellular carcinoma: recent advances and emerging medical therapies.
Journal: F1000Research
Published: June 01, 2020
B-1 cell response and its regulation during influenza virus infection.
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: November 26, 2019
A large real-world cohort study examining the effects of long-term entecavir on hepatocellular carcinoma and HBsAg seroclearance.
Journal: Journal of viral hepatitis
Published: April 01, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026